StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.73+0.26 (+3.07%)

Close on Nov 18, 2026Market cap $3.27BP/E –Yield –

Bausch Health Companies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Bausch Health Companies's operating income for the twelve months ending Sep 30, 2026 was $1.25B, down 34.3% year over year. For fiscal 2025 it was $1.81B, up 17.3% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $2.00B in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.81B+17.3%
FY2024Dec 31, 2024$1.55B+60.5%
FY2023Dec 31, 2023$963.00M+112.1%
FY2022Dec 31, 2022$454.00M+0.9%
FY2021Dec 31, 2021$450.00M-33.4%
FY2020Dec 31, 2020$676.00M–
FY2019Dec 31, 2019-$203.00M–
FY2018Dec 31, 2018-$2.38B-2437.3%
FY2017Dec 31, 2017$102.00M–
FY2016Dec 31, 2016-$566.00M-137.1%
FY2015Dec 31, 2015$1.53B-23.7%
FY2014Dec 31, 2014$2.00B–
FY2013Dec 31, 2013-$409.50M-613.8%
FY2012Dec 31, 2012$79.70M-73.4%
FY2011Dec 31, 2011$299.96M–
FY2010Dec 31, 2010-$110.09M-160.8%
FY2009Dec 31, 2009$181.15M+46.0%
FY2008Dec 31, 2008$124.11M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$983.00M+58.8%
Q2 FY2026Jun 30, 2026$740.00M+66.7%
Q1 FY2026Mar 31, 2026-$950.00M-444.2%
Q4 FY2025Dec 31, 2025$474.00M-15.1%
Q3 FY2025Sep 30, 2025$619.00M+94.7%
Q2 FY2025Jun 30, 2025$444.00M+14.1%
Q1 FY2025Mar 31, 2025$276.00M-1.8%
Q4 FY2024Dec 31, 2024$558.00M+54.1%
Q3 FY2024Sep 30, 2024$318.00M+2171.4%
Q2 FY2024Jun 30, 2024$389.00M-5.6%
Q1 FY2024Mar 31, 2024$281.00M+60.6%
Q4 FY2023Dec 31, 2023$362.00M–
Q3 FY2023Sep 30, 2023$14.00M-94.3%
Q2 FY2023Jun 30, 2023$412.00M+155.9%
Q1 FY2023Mar 31, 2023$175.00M-38.6%
Q4 FY2022Dec 31, 2022-$236.00M-164.3%
Q3 FY2022Sep 30, 2022$244.00M-57.5%
Q2 FY2022Jun 30, 2022$161.00M–
Q1 FY2022Mar 31, 2022$285.00M–
Q4 FY2021Dec 31, 2021$367.00M–
Q3 FY2021Sep 30, 2021$574.00M+24.8%
Q2 FY2021Jun 30, 2021-$270.00M–
Q1 FY2021Mar 31, 2021-$221.00M-189.1%
Q4 FY2020Dec 31, 2020-$5.00M–
Q3 FY2020Sep 30, 2020$460.00M+39.8%
Q2 FY2020Jun 30, 2020-$27.00M-110.5%
Q1 FY2020Mar 31, 2020$248.00M-13.6%
Q4 FY2019Dec 31, 2019-$1.08B-4404.0%
Q3 FY2019Sep 30, 2019$329.00M+181.2%
Q2 FY2019Jun 30, 2019$257.00M–
Q1 FY2019Mar 31, 2019$287.00M–
Q4 FY2018Dec 31, 2018$25.00M–
Q3 FY2018Sep 30, 2018$117.00M+207.9%
Q2 FY2018Jun 30, 2018-$245.00M-240.0%
Q1 FY2018Mar 31, 2018-$2.28B-1181.0%
Q4 FY2017Dec 31, 2017-$322.00M-314.7%
Q3 FY2017Sep 30, 2017$38.00M–
Q2 FY2017Jun 30, 2017$175.00M–
Q1 FY2017Mar 31, 2017$211.00M–
Q4 FY2016Dec 31, 2016$150.00M–

More Bausch Health Companies figures

See a number that looks wrong?